Checking CLYM unusual options activity helps you spot when traders are making outsized bets on Climb Bio Inc before the broader market catches on. Climb Bio Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor CLYM unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching CLYM unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking CLYM unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and CLYM unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. It develops budoprutug, an anti-CD19 monoclonal antibody for various autoimmune diseases, including systemic lupus erythematosus and lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wilmington, Delaware.
Catalysts rarely arrive without a footprint, and CLYM unusual options activity is often where that footprint shows up first. Our scanner tracks Climb Bio Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at CLYM unusual options volume on the call side or chasing put sweeps, Climb Bio Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
